José F. Rodríguez-Orengo to HIV Infections
This is a "connection" page, showing publications José F. Rodríguez-Orengo has written about HIV Infections.
Connection Strength
0.582
-
Ram?rez-Marrero FA, Rivera-Brown AM, Nazario CM, Rodr?guez-Orengo JF, Smit E, Smith BA. Self-reported physical activity in Hispanic adults living with HIV: comparison with accelerometer and pedometer. J Assoc Nurses AIDS Care. 2008 Jul-Aug; 19(4):283-94.
Score: 0.125
-
Rodr?guez-Torres M, Rodr?guez-Orengo JF, R?os-Bedoya CF, Fern?ndez-Carbia A, Marxuach-Cu?tara AM, L?pez-Torres A, Jim?nez-Rivera J. Effect of hepatitis C virus treatment in fibrosis progression rate (FPR) and time to cirrhosis (TTC) in patients co-infected with human immunodeficiency virus: a paired liver biopsy study. J Hepatol. 2007 Apr; 46(4):613-9.
Score: 0.113
-
Rodr?guez-Torres M, Rodr?guez-Orengo JF, R?os-Bedoya CF, Fern?ndez-Carbia A, Gonz?lez-Lassalle E, Salgado-Mercado R, Marxuach-Cu?tara AM. Efficacy and safety of peg-IFN alfa-2a with ribavirin for the treatment of HCV/HIV coinfected patients who failed previous IFN based therapy. J Clin Virol. 2007 Jan; 38(1):32-8.
Score: 0.111
-
Rodr?guez-Torres M, R?os-Bedoya CF, Rodr?guez-Orengo J, Fern?ndez-Carbia A, Marxuach-Cu?tara AM, L?pez-Torres A, Salgado-Mercado R, Br?u N. Progression to cirrhosis in Latinos with chronic hepatitis C: differences in Puerto Ricans with and without human immunodeficiency virus coinfection and along gender. J Clin Gastroenterol. 2006 Apr; 40(4):358-66.
Score: 0.107
-
Santana JL, Rodr?guez-Medina JR, Rodr?guez-Orengo JF. Clinical challenges and controversies in the management of HIV/ HCV-coinfected individuals. P R Health Sci J. 2004 Jun; 23(2 Suppl):35-40.
Score: 0.094
-
Laspiur JP, Anderson ER, Ciborowski P, Wojna V, Rozek W, Duan F, Mayo R, Rodr?guez E, Plaud-Valent?n M, Rodr?guez-Orengo J, Gendelman HE, Mel?ndez LM. CSF proteomic fingerprints for HIV-associated cognitive impairment. J Neuroimmunol. 2007 Dec; 192(1-2):157-70.
Score: 0.030